Interaction of oxidized low-density lipoprotein (LDL) with arterial smooth muscle cells (SMC) is believed to play a key role in the development of atherosclerosis. Depending on the extent of oxidation, apolipoproteins and/or lipids in the particle may be modified and thus lead to different cellular responses (e.g. proliferation or cell death). Here we report on the signaling effects of LDL, in which only the lipids were oxidized. This so-called minimally modified LDL (mmLDL) mainly activated components involved in stress response and apoptotic cell death including p38 mitogen-activated protein kinase (MAPK) and c-Jun N-terminal kinase/stress-activated protein kinase (JNK) as well as neutral and acid sphingomyelinase. In contrast, proliferative signaling elements such as extracellular regulated kinase, AKT-kinase and phospho-BAD seem to play a minor role as they were only slightly stimulated by mmLDL.
Introduction
The presence of oxidized low-density lipoprotein (LDL) in plasma and the arterial wall plays a main role in the development of atherosclerosis as a consequence of protein and lipid oxidation in the particle [1] . Much is known about the individual interactions of oxidized LDL (oxLDL) with macrophages, endothelial cells and smooth muscle cells (SMC), and their contribution to the formation of atherosclerotic plaques [2] . In this context, smooth muscle cells are especially important as they change their cell type after interaction with oxLDL [3] , proliferate and migrate from the arterial media into the intima where they continue to proliferate and produce collagenous fibers and extracellular matrix [4] . In addition, in the late phase of atherosclerosis they may undergo cell death by necrosis or apoptosis [5] , which is detrimental for the stability of the plaques. The mechanisms underlying oxLDL-triggered apoptosis or proliferation of smooth muscle cells are still not fully understood. So far, only studies have been carried out concerning the effects of highly oxidized LDL on signaling pathways using lipoproteins that were both oxidized at their protein and lipid moieties [6] . Thus, a specific role of the lipid and protein components in this scenario could not be identified.
On the other hand minimally modified LDL (mmLDL) is a physiologically very useful model, as it is only (or perhaps mainly) oxidized in the lipid domain [7] . It contains, in contrast to oxLDL, a largely intact apolipoprotein and is still recognized by the LDL receptor [8] . We addressed ourselves to the question as to whether mmLDL as compared to native LDL is able to trigger signaling pathways leading to apoptosis or proliferation of smooth muscle cells. The emphasis of our studies was the role of the protein kinases involved and the potential function of ceramide, a lipid mediator responsible for the induction of various cellular events like apoptosis, migration, and proliferation [9] . In this context, we tried to find out whether it is an upstream element of mmLDL-induced MAP kinase activation. Ceramideq, is generated from sphingomyelin by the action of sphingomyelinases (SMase) [10] . Several isoforms of these enzymes have been identified but mainly two are important for signal transduction, namely acid and neutral sphingomyelinase (nSMase) [11] . Our work was aimed at identifying the sphingomyelinase involved in signaling pathways in smooth muscle cells triggered by mmLDL.
In this study, we investigated the effects of mmLDL on cJun N-terminal kinase (JNK) and p38 MAPK, which are involved in apoptotic and stress response. Furthermore, activation of the protein kinases ERK and AKT which participate in proliferative and survival pathways was studied. Experiments with a new compound N,N,N-(3-carbazolylpropyl)-( p-methoxyphenylethyl)methylamine (NB6) as a specific inhibitor of acid sphingomyelinase (aSMase) on the transcriptional level [12] , were performed to examine the role of aSMase as an upstream element in mmLDL-induced activation of kinases cascades.
Materials and methods

Materials
Chemicals were purchased from Merck (Darmstadt, Germany). Plasticware for cell culture was from Sarstedt (Nürmbrecht, Germany). Media and supplements for cell culture were purchased from Paa Laboratories (Linz, Austria). C 6 -Ceramide was from Calbiochem (La Jolla, CA). NB6 was kindly provided by Hans-Peter Deigner (Clinic for Anaesthesiology and Intensive Care Therapy, FSU Jena, Germany). D609 was from Tocris Cookson (Avonmouth, UK). Chemicals for gel-electrophoreses were purchased from Bio-Rad Laboratories (Hercules, CA). Nitrocellulose membranes were from Schleicher & Schuell (Dassel, Germany). Primary polyclonal antibodies against phosphorylated forms of JNK, p38 MAPK, ERK1/2, AKT and BAD and against the nonphosphorylated proteins were purchased from New England Biolabs (Beverly, MA). Primary antibody against ASM was from Santa Cruz Biotechnology Inc (Santa Cruz, CA). Alkaline phosphatase-conjugated secondary antibodies and 5-bromo-4-chloro-3-indolylphosphate/nitro blue tetrazolium (BCIP/ NBT) liquid substrate system for alkaline phosphatase were from Sigma (Vienna, Austria).
Cell culture
Human transformed smooth muscle cells (ACBRI #443 Human Coronary Artery smooth muscle cells from Applied Cell Biology Research Institute, Kirkland, WA, USA) were routinely grown in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% FCS, 2 mM L-glutamine, 100 U/ml penicillin/streptomycin and 25 mM Hepes at 37jC q in humidified CO 2 (8%) atmosphere. For SMase experiments and Western blot analysis of cell lysates, cells were growth-arrested by incubation with DMEM + 0.1% FCS for 24 h prior to treatment with native LDL, mmLDL, ceramide, or NB6 in DMEM + 0.1% FCS.
Isolation and modification of LDL
Human LDL (d = 1.019 -1.063) was isolated from pooled fresh plasma using a Beckman NVT-rotor [13] . LDL was minimally modified (mmLDL) as described by Watson [14] and sterile filtered to avoid endotoxin contamination. According to the described procedure, mildly oxidized LDL was obtained. It is characterized by a moderate content of lipid peroxidation products (30 -60 nmol of peroxide equivalents/mg of apolipoprotein B [15] , a slightly enhanced electrophoretic mobility (REM) (0.34) as compared to native LDL (0.30) in 0.8% agarose gels z and an intact protein moiety.
The protein content of isolated and modified LDL was determined by the method of Lowry et al. [16] .
The whole isolation and modification procedure was carried out under sterile conditions. Solutions were prepared using endotoxin-free water followed by sterile filtering.
Determination of sphingomyelinase activity
Human arterial smooth muscle cells (HASM) were grown in six-well plates to 80% q confluency, growtharrested with DMEM + 0.1% FCS for 24 h and incubated afterwards with native LDL, mmLDL (60 Ag apo B/ml) or C 6 -ceramide (10 AM) for 30 min. For studying the effects of NB6 and D609, respectively, cells were pretreated with 10 AM of the respective substance for 30 min. NB6 was removed afterwards and cells were then exposed to mmLDL or ceramide as indicated above.
After treatment of smooth muscle cells with the respective compounds, cells were washed with cold PBS, scraped, harvested and lysed by incubation with neutral lysis buffer for determination of nSMase activity or acid lysis buffer for determination of aSMase activity as described previously [17] . Cell lysates were subjected to protein quantification after the method by Bradford [18] and aliquots containing 20 Ag protein were analyzed for acid and neutral SMase using fluorescent sphingomyelin as described [17] .
2.5. Western blot analysis of ASM and phosphorylation of JNK, p38 MAPK, ERK1/2, AKT and BAD HASM were grown in petri dishes (F = 10 cm) to 80% confluency in DMEM + 10% FCS, growth-arrested for 24 h in DMEM + 0.1% FCS and incubated afterwards with native LDL, mmLDL (60 Ag apo B/ml) or C 6 -ceramide (10 AM) for 5-30 min in DMEM + 0.1% FCS. Additionally, cells were pretreated with NB6 (10 AM) for 30 min before incubation with mmLDL and ceramide for 30 min. After treatment with the respective compounds, cells were washed with ice-cold PBS, scraped, harvested and lysed with homogenization buffer (20 mM Hepes-Na, 2 mM EDTANa 2 , 10 mM EGTA, 300 mM sucrose, 10 mM DTT, 1 mM PMSF, 300 AM NaF, 10 Ag/ml leupeptin, 10 Ag/ml benzamidin, 10 Ag/ml soya bean trypsin inhibitor, 1% Triton X-100, pH 7.6) followed by freezing at À 80 jC, thawing and vortexing. The protein content of cell lysates was determined by the method of Bradford [18] and aliquots containing 20 Ag protein were subjected to SDS-PAGE on 12% acrylamide gels using the mini-PROTEAN III electrophoresis cell according to Laemmli [19] . Proteins were transferred electrophoretically to nitrocellulose membranes. Unspecific binding was blocked by incubation of the membranes with 1% bovine serum albumin (BSA) in incubation buffer (50 mM Tris, 150 mM NaCl, 0.1% Tween 20 (v/v), pH 8.0). Blots were then incubated with primary antibodies against phosphorylated forms of JNK, p38 MAPK, ERK1/2, AKT1 (Ser473) and BAD (Ser136) (dilution 1:4000) or with primary antibody against ASM (dilution 1:400) in incubation buffer followed by incubation with alkaline phosphatase-conjugated anti-rabbit immunoglobulin (dilution 1:1500). Blots were developed with BCIP/NBT liquid substrate system. Loading controls using primary antibodies against unphosphorylated forms of JNK, p38 MAPK, ERK1/2 and AKT were performed following the same procedure.
Electron microscopy
HASM were grown in petri dishes (F = 10 cm) and growth-arrested as described. Afterwards they were incubated with or without mmLDL (60 Ag apo B/ml) in DMEM + 0.1% FCS. Cells were isolated and prefixed with 3% glutaraldehyde in 0.1 M cacodylate buffer, pH 7.2. After washing with cacodylate buffer, cells were fixed with 1% osmium tetroxide in the same buffer, dehydrated by passing the samples through a series of ethanol solutions of increasing strength (30 -100%) and embedded in Agar EPON 812. Ultrathin sections were prepared using a Leica Ultracut ultramicrotome, stained with uranyl acetate and lead citrate and viewed with a Philips EM 420 electron microscope.
Results
Activation of protein kinases by native LDL, mmLDL and ceramide
The effects of mmLDL and native LDL were investigated on activities of the mitogen-activated protein kinases (MAPKs) c-Jun N-terminal kinase/stress-activated kinase (JNK), p38 MAPK and extracellular regulated kinase 1/2 (ERK1/2) in SMCs. JNK and p38 MAPK, which are involved in stress response, inflammation and apoptosis [20, 21] , are phosphorylated to a substantially higher extent upon stimulation with mmLDL (60 Ag apo B/ml) than by native LDL (60 Ag apo B/ml, Fig. 1 ). In both cases, the activation maximum was reached after 10 min of incubation with mmLDL. In contrast, phosphorylation of ERK, which plays an important role in proliferation, growth and differentiation [22] , is induced by native LDL to a larger extent than by mmLDL within 5-30 min.
In order to understand which upstream signaling elements are involved in mmLDL-triggered activation of MAPKs the effects of ceramide were studied. Ceramide activated all three MAPKs under investigation (Fig. 1 , right lane). Ceramide is formed by enzymatic hydrolysis from sphingomyelin. Thus, the effects of mmLDL on sphingomyelinases in smooth muscle cells were also studied (see following section).
In addition to ERK, AKT kinase is another protein kinase that plays an important role in cell proliferation and survival. Thus, it was of interest to find out whether this protein kinase and its substrate BAD get phosphorylated as a consequence of incubation of SMC with mmLDL. However, mmLDL (60 Ag apo B/ml) hardly stimulated phosphorylation of AKT and BAD (Fig. 2) . In contrast, stimulation of cells with native LDL (60 Ag apo B/ml) for 30 min resulted in a noticeable increase of both AKT and BAD phosphorylation. Ceramide (10 AM) was able to induce phosphorylation of AKT and BAD in SMC as well, underlining its potential of mediating signals in both directions, cell death and growth.
In all these cases, the unphosphorylated forms of MAPKs and AKT were not affected by either natLDL, mmLDL or ceramide.
Effect of mmLDL and native LDL on neutral and acid sphingomyelinase
SMases generate ceramide, and thus, participate in signaling leading to apoptosis or proliferation depending on the conditions of oxidative stress [23] . mmLDL (60 Ag apo B/ml) induced a substantial increase of aSMase activity up to 200% as compared to the untreated control whereas native LDL showed much lower effects (130% activity of control, Fig. 3 ). nSMase activity was also stimulated by mmLDL up to 300% of control, but nearly the same extent of nSMase activation was found upon incubation of SMC with native LDL for 30 min (260% of control).
Effect of an inhibitor of aSMase on ceramide-and mmLDL-induced activation of sphingomyelinases
To find out whether the MAPKs p38 and JNK on the one hand or ERK and AKT on the other hand are potential downstream targets of acid sphingomyelinase, we ''removed'' the enzyme from the signaling cascade by treatment of SMCs with NB6. The latter compound specifically inhibits aSMase expression (and activity) in macrophages Fig. 3 . Effects of native and mmLDL on aSMase and nSMase activity. HASM were treated with native or mmLDL for 30 min, followed by isolation and lysis in lysis buffer for assaying neutral and acid SMase, respectively. Enzyme activities were determined as described previously [17] . Data shown are mean F S.D. (n z 3 -5) . Fig. 4 . Effects of mmLDL, ceramide and NB6 on aSMase. (A) Cells were stimulated with mmLDL (60 Ag apo B/ml) or ceramide (10 AM) after or without pretreatment with NB6 (10 AM) for 30 min followed by cell lysis in acid lysis buffer. Enzyme activities were determined using NBD-labelled sphingomyelin as substrate [17] . NBD-ceramide formed was separated from the remaining substrate by TLC on silica gel. An image of TLC analysis of fluorescent NBD-lipids is shown which was obtained using a CCD-camera. and fibroblasts [12] . We found that NB6 also reduced protein levels and activity of acid sphingomyelinase in smooth muscle cells (see Fig. 4 ). As a consequence, mmLDL-and ceramide-induced activation of this enzyme was abolished as well.
For determination of enzyme activity fluorescent N-7-nitrobenz-2-oxa-1,3-diazol (NBD)-sphingomyelin was used as a substrate to measure SMase activity from the amount of NBD-ceramide formed [17] . Fig. 4 shows the formation of fluorescent ceramide as a consequence of cell stimulation and aSMase-activation by mmLDL (60 Ag/ml) or C 6 -ceramide (10 AM) for 30 min. C 6 -Ceramide was taken as the stimulus in this case since some studies had already revealed that ceramide itself could act as an inducer q of SMase activity in macrophages and other cells via a possible auto-feedback mechanism [12] . Pretreatment of SMC with NB6 inhibited stimulation of acid sphingomyelinase activity by mmLDL or ceramide. aSMase activity in cells pretreated with NB6 was even lower than SMase activity in untreated and unstimulated controls. Fig. 4C shows Western blots demonstrating that NB6 (10 AM, 10 -30 min) significantly reduced protein levels of acid sphingomyelinase, too. This is in line with the effects that NB6 shows on expression of aSMase in fibroblasts and macrophages [12] .
In order to confirm that NB6 specifically inhibited aSMase and did not affect the neutral isoform, nSMase activity after pretreatment with NB6 was investigated. Activation of this SMase isoform by mmLDL or ceramide was not influenced by NB6 (Fig. 5) .
It has to be emphasized that the experiments involving NB6 were solely carried out to confirm that the presence of aSMase protein is required for initiating the apoptotic MAP kinase cascade. It has nothing to do with the mechanisms of aSMase activation itself, which is very likely to be induced physically on the protein or membrane level, since activation requires only a few minutes of contact between the cells and the stimuli (ceramide or mmLDL). 3.4. Influence of the aSMase-specific inhibitor NB6 on mmLDL-and ceramide-induced activation of MAPKs, AKT/ PKB and BAD Since NB6 was identified as a specific inhibitor of aSMase at a transcriptional level (see above), it was further applied to study the role of this enzyme in mmLDL-and ceramide-induced signaling. Thus, aSMase expression was reduced by preincubation of cells with NB6, prior to stimulation with mmLDL or ceramide.
NB6 prevented mmLDL-and ceramide-induced activation of JNK and p38 MAPK, whereas it did not show any effects on phosphorylation of ERK1/2 (Fig. 6A) . mmLDLand ceramide-induced phosphorylation of AKT and BAD also remained unaffected after pretreatment with the aSMase inhibitor (Fig. 6B) . Thus, aSMase is rather involved as an upstream element of JNK and p38 MAPK in mmLDLinduced (apoptotic) signaling in SMC. Phosphorylation of JNK and p38 MAPK as a consequence of cell stimulation by ceramide was also inhibited by NB6. Hence, aSMase seems to be activated by an auto-feedback mechanism involving ceramide, its enzymatic product. On the other hand, aSMase in smooth muscle cells is not very likely to be involved in signaling q, leading to proliferation q.
Influence of the aSMase-inhibitor D609 on mmLDLinduced activation of p38 MAPK and JNK
In order to exclude the possibility that NB6 interferes directly with one of the MAPKs, the effect of NB6 on p38 MAPK and JNK was compared to the action of the welldescribed and very specific aSMase-pathway inhibitor D609 [24] [25] [26] [27] . Fig. 8 shows that D609, like NB6 abrogated mmLDL-induced activation of p38 MAPK and JNK (Fig.  7) providing additional evidence for the assumption that aSMase is upstream of these two protein kinases. Since NB6 and D609 act very much the same way in inhibiting aSMase, we may at least conclude that direct interaction of both inhibitors with downstream MAPKs are very unlikely.
Morphological changes of smooth muscle cells induced by mmLDL
Since mmLDL activated apoptotic signaling in SMCs, we investigated the possibility that morphological changes of the cells typical of apoptosis would also occur. For this purpose we used transmission electron microscopy. After treatment with mmLDL (60 Ag apo B/ml), human arterial smooth muscle cells showed all signs of apoptotic cell death. In contrast to the untreated control (Fig. 8, left) , the cells exposed to mmLDL (Fig. 8, right) showed membrane blebbing, fragmentation of the nucleus, chromatin condensation and decrease of cell volume. Smooth muscle cells treated with native LDL for 8 h did not show any morphological changes at all (data not shown).
Discussion
Proliferation and apoptosis of arterial SMC play an important role in the development of atherosclerosis. Whereas cell proliferation contributes to the formation of the atherosclerotic plaques at the earlier stages of atherosclerosis, apoptosis occurs in the later phases and can be detrimental, since SMC produce most of the interstitial collagen fibers important for the tensile strength of the fibrous cap. Thus the presence of apoptotic smooth muscle cells in atherosclerotic lesions contributes to the instability of the lesion and cell death might also be a primary cause for induction of inflammatory responses [5] . Fig. 7 . Effects of NB6 as compared to D609 on phosphorylation of JNK and p38 MAPK. Cells were incubated with mmLDL (60 Ag apo B/ml) after or without pretreatment with NB6 and D609 (10 AM each), for 30 min, respectively. Western blots for determination of phosphorylated JNK and p38 MAPK as well as total MAPKs were performed as described in the legends to Figs. 1 and 2 . Oxidized LDL is an important risk factor in the formation of atherosclerotic plaques. It exerts various effects on all cells of the arterial wall by triggering very different responses. Depending on concentration and the extent of oxidation, oxLDL may lead to both proliferation and apoptosis of smooth muscle cells [28, 29] . Most studies concerning the effects of oxLDL on SMCs were carried out with highly oxidized LDL. This particle contains both oxidized proteins and lipids. A less extensively oxidized form of LDL is represented by mmLDL, which contains oxidized lipids and hardly shows any protein modification. It resembles much more the oxLDL present in vivo [30] .
Proliferative and apoptotic responses of SMCs to oxidative stress are mediated by several signal transduction pathways [4, 5] . The sphingolipid ceramide plays a key role as a mediator in numerous signaling pathways induced by a variety of stress factors in various cell types including mitogens or cytokines such as TNFa, IFNg, IL-1, FasL, PDGF, UV as well as oxLDL [31] . It is formed after activation of sphingomyelinases under the influence of the above substances [9] . Two enzyme isoforms play a key role in signal transduction, namely a neutral Mg 2 + -dependent sphingomyelinase and an acid isoform, both of which can be activated by stress, e.g. by oxLDL [32] . It was the aim of this study to identify the role of sphingomyelinases and their product ceramide on the signaling cascades in SMC that are triggered by mmLDL.
nSMase was activated by native LDL and mmLDL to a similar extent. In contrast, aSMase was activated much more efficiently by mmLDL than by native LDL. SMase activation was accompanied by fast phosphorylation of p38 MAPK and JNK, which are involved in stress response, inflammation and apoptosis [20, 21] . These effects were not observed when the cells were stimulated with native LDL. Obviously, the oxidized lipid component must be responsible for the effects of mmLDL on acid sphingomyelinase, p38 MAPK and JNK since both lipoproteins (native LDL and mmLDL) contain the same (unmodified) apolipoprotein B. On the other hand, activation of aSMase and the protein kinases was induced by ceramide. We conclude from this observation that ceramide may serve a dual function. On the one hand, it acts as a second messenger to propagate the mmLDL signal. On the other hand, it acts via a positive feedback mechanism since it potentiates the action of the enzyme by which it is generated. mmLDL failed to stimulate the phosphorylation of another member of the MAPK family namely p42/44 MAPK (ERK), which is involved in induction of proliferation, growth and migration [22] . However, the latter enzyme was phosphorylated upon exposure of SMCs to native LDL. This is in line with observations by Locher et al. [33] , who demonstrated that native LDL gives rise to the formation of ROS and subsequent activation of ERK, which might be important for mitogenic signaling in SMCs. Activation of ERK was also observed after stimulation of SMC by ceramide, suggesting that SMases might play a role in this context as well.
Furthermore, the effects of mmLDL and native LDL on AKT kinase was studied, which counteracts apoptosis. This protein is phosphorylated by PDKs and as such inhibits programmed cell death since it phosphorylates and, as a consequence, inhibits BAD, an apoptotic member of the Bcl2-family [34] . mmLDL hardly showed any effects on AKT phosphorylation, whereas cell treatment by native LDL or ceramide led to high phosphorylation of AKT and BAD. Obviously, ceramide is involved as a lipid mediator in apoptotic and anti-apoptotic signaling pathways depending on the conditions of activation.
Our results are at variance with other studies reporting on the induction of SMC proliferation and activation of ERK and AKT by oxLDL [35 -37] . However, these studies were carried out with highly oxidized LDL, in which both the protein and lipid components were modified. In contrast, our experiments were performed with mmLDL, in which mainly the lipid domains are oxidized. The differences among our results and those obtained from other groups give another hint that the signaling pathways investigated in this study are triggered, if at all, by the oxidized lipid component of mmLDL. In contrast, activation of proliferative and survival pathways like AKT and ERK by oxLDL might be due to the action of oxidized apolipoproteins guiding the lipoprotein particle to the scavenger [38] instead of the apo B/E receptor and thus, another signaling pathway.
SMases are essential catalysts for the formation of ceramide as upstream elements in mmLDL-induced signaling in SMC. To find out whether aSMase is responsible for the ceramide-associated signaling in this study, we used a novel inhibitor of aSMase (NB6) which suppresses protein synthesis at the transcriptional level [12] . We provided Fig. 9 . Intracellular signaling induced by mmLDL. mmLDL induces specific signaling cascades via generation of ceramide by acid sphingomyelinase followed by activation of p38 MAPK and JNK. Ceramide in turn, stimulates aSMase via an auto-feedback mechanism, thus amplifying the signal transmitted to the downstream targets p38 MAPK and JNK. Survival and proliferation pathways depending on ERK and AKT/PKB are not activated. As a consequence, mmLDL preferentially leads to apoptosis of vascular smooth muscle cells.
evidence that NB6 reduced aSMase protein levels in SMCs and that reduction of aSMase expression specifically inhibits subsequent activation of aSMase by mmLDL or ceramide. In contrast, it did not show any effects on mmLDL-and ceramide-triggered activation of the neutral isoform.
Activation of aSMase seems to be reinforced by a positive feedback mechanism, involving ceramide, which is formed by this enzyme (Fig. 9) . Ceramide shows a wide spectrum of biophysical and biochemical activities. In membranes, it may induce microdomains, ceramide channels or vesicle budding. As a second messenger it may affect various enzymes of intracellular signaling [39, 40] . In the latter context, it does not only activate MAPKs and AKT kinase, but also sphingomyelinases, thus amplifying the primary signal of the cascade. This assumption is further supported by the finding that reduction of aSMase protein levels by NB6 inhibited both mmLDL-and ceramide-induced activation of aSMase. In addition, this compound abrogated mmLDL-or ceramide-induced phosphorylation of the apoptotic protein kinases p38 MAPK and JNK by means of inhibition of aSMase expression. In contrast, phosphorylation of ERK, AKT and BAD, the elements involved in cell proliferation and survival, was not affected by NB6. Taken together these data suggest an essential and specific role for aSMase in apoptotic signaling of smooth muscle cells under the influence of mmLDL.
